Drugs / Haploidentical Natural Killer (NK) Cells
Haploidentical Natural Killer (NK) Cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03899480 | May 2019 → Apr 2021 | HIV infectious disease, immunodeficiency disease | University of Minnesota | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Haploidentical Natural Killer (NK) Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03899480 ↗ |
| Modality | Cell therapy | “infusion with N-803 activated NK cells” NCT03899480 ↗ |